Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 156
Filter
1.
Acta Neurol Scand ; 136(1): 59-63, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27726124

ABSTRACT

OBJECTIVES: Primary familial brain calcification (PFBC) is a rare neurological disease often inherited as a dominant trait. Mutations in four genes (SLC20A2, PDGFB, PDGFRB, and XPR1) have been reported in patients with PFBC. Of these, point mutations or small deletions in SLC20A2 are most common. Thus far, only one large deletion covering entire SLC20A2 and several smaller, exonic deletions of SLC20A2 have been reported. The aim of this study was to identify the causative gene defect in a Finnish PFBC family with three affected patients. MATERIALS AND METHODS: A Finnish family with three PFBC patients and five unaffected subjects was studied. Sanger sequencing was used to exclude mutations in the coding and splice site regions of SLC20A2, PDGFRB, and PDGFB. Whole-exome (WES) and whole-genome sequencing (WGS) were performed to identify the causative mutation. A SNP array was used in segregation analysis. RESULTS: Copy number analysis of the WGS data revealed a heterozygous deletion of ~578 kb on chromosome 8. The deletion removes the 5' UTR region, the noncoding exon 1 and the putative promoter region of SLC20A2 as well as the coding regions of six other genes. CONCLUSIONS: Our results support haploinsufficiency of SLC20A2 as a pathogenetic mechanism in PFBC. Analysis of copy number variations (CNVs) is emerging as a crucial step in the molecular genetic diagnostics of PFBC, and it should not be limited to coding regions, as causative variants may reside in the noncoding parts of known disease-associated genes.


Subject(s)
Brain Diseases/genetics , Calcinosis/genetics , Gene Deletion , Sodium-Phosphate Cotransporter Proteins, Type III/genetics , 5' Flanking Region , Brain Diseases/diagnosis , Calcinosis/diagnosis , DNA Copy Number Variations , Exome , Female , Heterozygote , Humans , Male , Pedigree , Point Mutation , Xenotropic and Polytropic Retrovirus Receptor
2.
Acta Neurol Scand ; 132(6): 430-4, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25819272

ABSTRACT

BACKGROUND: CADASIL is an inherited systemic small vessel disease, the affected status of brain vessels leading to subcortical vascular dementia. The defective gene is NOTCH3 in which over 230 different pathogenic mutations have been identified. The clinical course of CADASIL is highly variable even within families. Previous studies have shown that additional genetic factors modify the phenotype. AIMS AND METHODS: Altogether, 134 Finnish CADASIL patients with p.Arg133Cys mutation were analysed for possible associations between the apolipoprotein E (APOE) genotype, angiotensinogen (AGT) p.Met268Thr polymorphism or neutral p.Ala202Ala NOTCH3 polymorphism and earlier first-ever stroke or migraine. RESULTS: We found no association between the APOE genotypes, AGT polymorphism, NOTCH3 polymorphism and earlier first-ever stroke or migraine. CONCLUSIONS: The APOE, AGT and NOTCH3 polymorphism did not modify the onset of strokes or migraine in our CADASIL sample, which is one of the largest mutationally homogenous CADASIL populations published to date. International collaboration, pooled analyses and genomewide approaches are warranted to identify the genetic factors that modify the highly variable CADASIL phenotype.


Subject(s)
Angiotensinogen/genetics , Apolipoproteins E/genetics , CADASIL/epidemiology , CADASIL/genetics , Adult , Age of Onset , Aged , Aged, 80 and over , Female , Finland/epidemiology , Gene Frequency , Humans , Male , Middle Aged , Migraine Disorders/etiology , Mutation , Phenotype , Polymorphism, Single Nucleotide/genetics , Receptor, Notch3 , Receptors, Notch/genetics , Stroke/epidemiology , Young Adult
3.
Eur J Nucl Med Mol Imaging ; 40(10): 1567-72, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23801168

ABSTRACT

PURPOSE: Cortical glucose metabolism, brain amyloid ß accumulation and hippocampal atrophy imaging have all been suggested as potential biomarkers in predicting which patients with mild cognitive impairment (MCI) will convert to Alzheimer's disease (AD). The aim of this study was to compare the prognostic ability of [(11)C]PIB PET, [(18)F]FDG PET and quantitative hippocampal volumes measured with MR imaging in predicting conversion to AD in patients with MCI. METHODS: The study group comprised 29 patients with MCI who underwent [(11)C]PIB PET and MR imaging. Of these, 22 also underwent [(18)F]FDG PET. All subjects were invited back for clinical evaluation after 2 years. RESULTS: During the follow-up time 17 patients had converted to AD while 12 continued to meet the criteria for MCI. The two groups did not differ in age, gender or education level, but the converter group tended to have lower MMSE and Word List learning than the nonconverter group. High [(11)C]PIB retention in the frontotemporal regions and anterior and posterior cingulate (p < 0.05) predicted conversion to AD. Also reduced [(18)F]FDG uptake in the left lateral temporal cortex (LTC) predicted conversion (p < 0.05), but quantitative hippocampal volumes did not (p > 0.1). In receiver operating characteristic (ROC) analysis the measurements that best predicted the conversion were [(11)C]PIB retention in the lateral frontal cortex and [(18)F]FDG uptake in the left LTC. Both PET methods resulted in good sensitivity and specificity and neither was significantly superior to the other. CONCLUSION: The findings indicate that [(11)C]PIB and [(18)F]FDG are superior to hippocampal volumes in predicting conversion to AD in patients with MCI.


Subject(s)
Benzothiazoles , Cognitive Dysfunction/diagnostic imaging , Fluorodeoxyglucose F18 , Magnetic Resonance Imaging , Positron-Emission Tomography , Radiopharmaceuticals , Aged , Aniline Compounds , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/physiopathology , Cognitive Dysfunction/diagnosis , Disease Progression , Female , Hippocampus/diagnostic imaging , Hippocampus/physiopathology , Humans , Male , Predictive Value of Tests , Thiazoles
4.
Acta Neurol Scand ; 126(1): 67-75, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22098561

ABSTRACT

BACKGROUND: Hereditary diffuse leukoencephalopathy with spheroids (HDLS) was first identified among a Swedish kindred with 17 cases. The average age of onset was 36 years. Autopsy in four cases revealed the presence of axonal spheroids. The causative gene is unknown. METHODS: We performed genealogical and longitudinal observations of the original kindred. Forty members were examined, five telephone-interviewed, and one of the original HDLS cases from 1984 was neuropathologically examined. The clinical course was documented. The cerebrospinal fluid (CSF) findings of two recently affected cases were examined, and one of those autopsied. RESULTS: Of those examined, two developed HDLS during our survey and 38 were healthy. Those interviewed by telephone were healthy. One had symptoms suggestive of HDLS in 1984, but autopsy during our survey showed no spheroids. This patient, two relatives healthy at our examination and one without symptoms at telephone interview had HDLS diagnoses in the 1984 report. Thus, four HDLS diagnoses were unconfirmed. The number of identified patients amounts to 15 among 75 individuals in four generations, including two recent cases who demonstrated a subacute multisystem encephalopathy in Case 1 and an insidious course in Case 2. CSF showed signs of neurodegeneration without inflammation, and autopsy verified HDLS in Case 1. CONCLUSIONS: Some HDLS cases were misdiagnosed with unspecified psychiatric diagnoses in affected relatives from the original 1984 publication. However, HDLS is an encephalopathy dominated by a frontal lobe syndrome with an inexorably progressive and fatal course, where the different symptomatology in two recent cases confirmed the existence of acute and chronic variants.


Subject(s)
Brain/pathology , Cognition Disorders/genetics , Leukoencephalopathies/genetics , Adult , Age of Onset , Aged , Aged, 80 and over , Axons/pathology , Cognition Disorders/pathology , Cognition Disorders/psychology , Disease Progression , Female , Follow-Up Studies , Humans , Leukoencephalopathies/pathology , Leukoencephalopathies/psychology , Longitudinal Studies , Male , Middle Aged , Pedigree , Sweden
5.
Neurology ; 76(12): 1085-90, 2011 Mar 22.
Article in English | MEDLINE | ID: mdl-21325653

ABSTRACT

BACKGROUND: Patients with amnestic mild cognitive impairment (MCI) have greater risk of conversion to Alzheimer disease (AD). Increased brain amyloid burden in AD and MCI has been demonstrated with PET using [(11)C] Pittsburgh compound B (PiB) as a tracer. OBJECTIVE: To evaluate change in ß-amyloid deposition in with MCI during 2-year follow-up. METHODS: Patients with MCI and controls were studied with [(11)C] PiB PET, MRI, and neuropsychometry at baseline and these investigations were repeated in patients with MCI after follow-up. RESULTS: Those patients with MCI converting to AD during follow-up had greater [(11)C] PiB retention in the posterior cingulate (p=0.020), in the lateral frontal cortex (p=0.006), in the temporal cortex (p=0.022), in the putamen (p=0.041), and in the caudate nucleus (p=0.025) as compared to nonconverters. In converters, there was no significant change in [(11)C] PiB uptake, whereas an increase was seen as compared to baseline in nonconverters in the anterior and posterior cingulate, temporal and parietal cortices, and putamen. Hippocampal atrophy was greater in converters at baseline than in nonconverters, but increased significantly in both groups during follow-up. CONCLUSIONS: Hippocampal atrophy and amyloid deposition seem to dissociate during the evolution of MCI, the atrophy increasing clearly and [(11)C] PiB retention changing modestly when conversion to AD occurs. Longer follow-up is needed to determine whether nonconverters would convert to AD later, which would suggest accelerated [(11)C] PiB retention preceding clinical conversion.


Subject(s)
Amyloid beta-Peptides/metabolism , Aniline Compounds , Brain/metabolism , Brain/pathology , Cognition Disorders/metabolism , Cognition Disorders/pathology , Positron-Emission Tomography/methods , Thiazoles , Aged , Alzheimer Disease/complications , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Atrophy/complications , Atrophy/diagnostic imaging , Brain/diagnostic imaging , Carbon Radioisotopes , Cognition Disorders/complications , Cognition Disorders/diagnostic imaging , Disease Progression , Female , Follow-Up Studies , Humans , Male , Neuropsychological Tests
6.
Eur J Clin Nutr ; 64(12): 1465-71, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20823898

ABSTRACT

BACKGROUND/OBJECTIVES: Repeated postprandial hyperglycemia and subsequent mild, late hypoglycemia as well as high postprandial insulin response lead to metabolic events that may eventually develop into type 2 diabetes. The aim of this study was to assess how sea buckthorn berries as well as two sea buckthorn extraction residues modulate the postprandial metabolism after a high-glucose meal. SUBJECTS/METHODS: Ten healthy normal-weight male volunteers consumed four study breakfasts, one control (A) and three sea buckthorn meals on four distinct study days. All the meals contained yoghurt and glucose (50 g). The sea buckthorn ingredients used were dried and crushed whole berries (meal B1), supercritical fluid (SF)-carbon dioxide (CO(2))-extracted oil-free berries (meal B2) or ethanol-extracted SF-CO(2)-extraction residue (meal B3). Blood samples for glucose, insulin and tumor necrosis factor-α analyses were collected before and during the 6-h study period. RESULTS: Meal B1 suppressed the postprandial peak insulin response when compared with meal A (Δconcentration of 30-min peak value--21.8 mU/l, P=0.039), and stabilized postprandial hyperglycemia and subsequent hypoglycemia (Δconcentration of 30-min peak value--120-min value -30.4 mU/l, P=0.036). Furthermore, meal B2 resulted in a more stable insulin response than the control meal (Δconcentration of 30-min peak value--120-min value -25.9 mU/l, P=0.037). CONCLUSIONS: Removal of the CO(2)-soluble oil component from the berries did not show a significant change in the studied postprandial effects of the berries. The EtOH soluble components, again showed advantageous properties in both insulin and glucose responses.


Subject(s)
Fruit/chemistry , Hippophae/chemistry , Hyperglycemia/metabolism , Insulin/blood , Adult , Blood Glucose/analysis , Humans , Hyperglycemia/prevention & control , Hypoglycemic Agents/analysis , Male , Postprandial Period , Tumor Necrosis Factor-alpha/blood , Young Adult
7.
Eur J Vasc Endovasc Surg ; 40(5): 618-25, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20418121

ABSTRACT

OBJECTIVES: To assess the quality of life (QoL) of peripheral arterial disease (PAD) patients who have undergone either percutaneous transluminal angioplasty (PTA) only and/or one or more surgical revascularizations. DESIGN: A postal questionnaire study in which a case-control methodology was applied. MATERIALS AND METHODS: 131 patients with PTAs (mean age 70.7, SD 10.4 yrs; range 39-89, 58% men) and 100 with surgical revascularizations (mean age 67.8, SD 10.4 yrs; range 43-91, 62% men), in 1998-2003, and their age- and gender-matched controls were studied. The mean time since the last revascularization for PTA was 2.7, SD 1.3 yrs and for operated patients 3.5, SD 1.8 yrs. Ankle-brachial pressure index (ABI) and Mini-Mental-State Examination (MMSE) score were obtained from 70% of the patients. QoL was assessed using 15D Health-related QoL instrument, Rand-36 Physical Functioning subscale, 6-item Brief Social Support Questionnaire, Geriatric Depression Scale (GDS), Self-reported Life Satisfaction (LS) score, and one 'perceived state of health' question. RESULTS: Patients after endovascular and/or surgical revascularization (most with ABIs 0.5-0.89 and without cognitive impairment), had similarly lower QoL, GDS and LS indicated more depression than their controls. CONCLUSION: Poor QoL and depression should be thoroughly considered, alongside proper follow-up and ABI-measurements.


Subject(s)
Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Quality of Life , Surveys and Questionnaires , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Lower Extremity/surgery , Male , Middle Aged , Vascular Surgical Procedures
8.
Neurology ; 73(15): 1186-92, 2009 Oct 13.
Article in English | MEDLINE | ID: mdl-19726751

ABSTRACT

OBJECTIVE: In Alzheimer disease (AD), the accumulation pattern of beta-amyloid over time and its relationship with dementia severity are unclear. We investigated the brain uptake of the amyloid ligand (11)C-labeled Pittsburgh compound B ([(11)C]PIB) and volumetric brain changes over a 2-year follow-up in patients with AD and in aged healthy controls. METHODS: Fourteen patients with AD (mean age 72 years, SD 6.6) and 13 healthy controls (mean age 68 years, SD 5.4) were examined at baseline and after 2 years (patients with AD: mean 2.0 years, SD 0.2; controls: mean 2.1 years, SD 0.6) with [(11)C]PIB PET, MRI, and neuropsychological assessments. [(11)C]PIB uptake was analyzed with a voxel-based statistical method (SPM), and quantitative data were obtained with automated region-of-interest analysis. MRI data were analyzed with voxel-wise tensor-based morphometry. RESULTS: The [(11)C]PIB uptake of the patients with AD did not increase significantly during follow-up when compared with that of the controls. MRI showed progressive brain volume change in the patients with AD, e.g., in the hippocampal region, temporal cortex, and precuneus (p < 0.05). The mean Mini-Mental State Examination score of the patients with AD declined from 24.3 (SD 3.1) at baseline to 21.6 (SD 3.9) at follow-up (p = 0.009). Cognitive decline was also evident in other neuropsychological test results. Baseline neocortical [(11)C]PIB uptake ratios predicted subsequent volumetric brain changes in the controls (r = 0.725, p = 0.005). CONCLUSIONS: The results suggest no (or only little) increase in (11)C-labeled Pittsburgh compound B ([(11)C]PIB) uptake during 2 years of Alzheimer disease progression, despite advancing brain atrophy and declining cognitive performance. Nevertheless, changes in [(11)C]PIB uptake during a longer follow-up cannot be excluded. High cortical [(11)C]PIB uptake may predict ongoing brain atrophy in cognitively normal individuals.


Subject(s)
Alzheimer Disease/pathology , Amyloid/metabolism , Aniline Compounds/metabolism , Brain/pathology , Thiazoles/metabolism , Aged , Aged, 80 and over , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/metabolism , Alzheimer Disease/psychology , Brain/diagnostic imaging , Brain/metabolism , Carbon Radioisotopes/metabolism , Case-Control Studies , Cognition , Disease Progression , Female , Follow-Up Studies , Humans , Male , Middle Aged , Organ Size , Radionuclide Imaging
9.
Neurochem Int ; 55(4): 243-52, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19524115

ABSTRACT

Mutations in presenilin (PS) and amyloid precursor protein (APP) genes are a predominant cause for early-onset familial Alzheimer disease (AD). Although these mutations are rare, they have in the past decades advanced our understanding of the underlying molecular mechanisms of AD. In the present study, Abeta levels were measured in cortical regions of APPsw and PS1 (M146V) mutation carriers, sporadic AD (SAD) and age-matched non-demented individuals. We found similar levels of soluble Abeta42, insoluble and soluble Abeta40 in both APPsw mutation carriers and SAD. However, lower levels of insoluble Abeta42 were detected in the frontal and temporal cortex of APPsw brain. In PS1 brain, insoluble Abeta40 and Abeta42 levels were significantly lower in all four cortical regions compared with SAD, whilst levels of Abeta40 were lower in frontal and occipital cortex compared with APPsw brain. The insoluble Abeta42/40 ratio was similar in SAD and APPsw but significantly higher in PS1 mutation carriers. Our results indicate that the pattern of Abeta deposition in PS1 mutation carriers differs from that in both APPsw and SAD, whereas the pattern in APPsw mutation carriers is more similar to that in SAD.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Brain/metabolism , Brain/pathology , Genetic Predisposition to Disease/genetics , Adult , Aged , Aged, 80 and over , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/analysis , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , DNA Mutational Analysis , Family Health , Female , Genetic Testing , Humans , Male , Middle Aged , Mutation/genetics , Peptide Fragments/analysis , Peptide Fragments/metabolism , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Presenilin-1/genetics
10.
Eur J Neurol ; 16(7): 808-13, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19453410

ABSTRACT

BACKGROUND: Elevated total homocysteine (tHcy) levels may be caused by vitamin B12 deficiency and are linked to Alzheimers disease (AD) in some studies, although the evidence is mixed. Another marker of vitamin B12 deficiency, holo-transcobalamin (holo-TC), has not been studied in a prospective setting. OBJECTIVE: To investigate the association between tHcy and holo-TC and the subsequent development of dementia and AD in a prospective study. METHODS: A sub-sample of 228 non-demented subjects was taken from the Kungsholmen Project, a population-based longitudinal study amongst persons 75+ years. tHcy and holo-TC were analysed at baseline. RESULTS: Increasing tHcy levels were related to an increased risk of dementia (n = 83) and AD (n = 61) after a mean follow-up time of 6.7 years. Persons with high tHcy (the fourth quartile) had more than twice as high a risk of developing AD than persons with low tHcy, even after adjusting for confounding or mediating factors. The third quartile of holo-TC was associated with a reduced risk of AD, after adjusting for Hcy and other confounders. CONCLUSIONS: These results suggest that Hcy is involved in the development of dementia and AD. The role of holo-TC was less clear and this marker needs to be studied further.


Subject(s)
Alzheimer Disease/epidemiology , Alzheimer Disease/metabolism , Dementia/epidemiology , Dementia/metabolism , Homocysteine/metabolism , Transcobalamins/metabolism , Aged , Aged, 80 and over , Community Health Planning , Female , Humans , Male , Models, Anatomic , Prospective Studies , Risk Assessment , Risk Factors , Severity of Illness Index
11.
Brain ; 131(Pt 7): 1845-53, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18583368

ABSTRACT

Variant Alzheimer's disease (VarAD) with spastic paraparesis and presenile dementia is associated with certain mutations of the presenilin 1 (PS-1) gene, particularly those leading to deletion of exon 9 (PS-1Delta E9). VarAD is neuropathologically characterized by the presence of unusually large, Abeta42 positive, non-cored 'cotton wool' plaques (CWPs), also devoid of dystrophic neurites. The aim of the present study was to find out whether [(11)C]PIB would show increased uptake and serve as an in vivo biomarker of amyloid accumulation in VarAD. A further aim was to assess the correspondence of the [(11)C]PIB binding to the amount and type of Abeta deposits in another group of deceased VarAD patients' brains. We studied four patients with VarAD and eight healthy controls with PET using [(11)C]PIB as tracer. Parametric images were computed by calculating the region-to-cerebellum and region-to-pons ratio in each voxel over 60-90 min. Group differences in [(11)C]PIB uptake were analysed with automated region-of-interest (ROI) analysis. [(11)C]PIB uptake was compared to the immunohistochemically demonstrated deposition of Abeta in the brains of another group of four deceased VarAD patients. Patients with VarAD had significantly higher [(11)C] PIB uptake than the control group in the striatum (caudate nucleus and putamen), anterior and posterior cingulate gyrus, occipital cortex and thalamus. In the caudate and putamen [(11)C]PIB uptake, expressed as region-to-cerebellum ratio, was on the average 43% greater than the mean of the control group. The increases in the anterior (28%) and posterior (27%) cingulate gyrus, occipital cortex (21%) and thalamus (14%) were smaller. All VarAD patients showed this similar topographical pattern of increased [(11)C]PIB uptake. The results were essentially similar when the uptake was expressed as region-to-pons ratios. [(11)C]PIB imaging shows increased uptake in patients with VarAD especially in the striatum, and it can be used to detect amyloid accumulation in vivo in these patients. The pattern of increased [(11)C]PIB uptake is different from that described in sporadic Alzheimer's disease and resembles that seen in Alzheimer's disease patients with certain presenilin-1 mutations or amyloid precursor protein gene duplication showing predominantly striatal increase in [(11)C]PIB uptake.


Subject(s)
Alzheimer Disease/diagnostic imaging , Corpus Striatum/diagnostic imaging , Aged , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Aniline Compounds , Benzothiazoles , Brain Mapping/methods , Carbon Radioisotopes , Caudate Nucleus/metabolism , Caudate Nucleus/pathology , Corpus Striatum/metabolism , Corpus Striatum/pathology , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Positron-Emission Tomography/methods , Thiazoles
12.
Accid Anal Prev ; 40(2): 452-60, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18329394

ABSTRACT

UNLABELLED: The aim of the study was to analyze the assessment procedure and identify predictors for the team decision when assessing fitness to drive a car after stroke. The material used was a retrospective data set with 200 stroke clients from Queen Elisabeth's Foundation Mobility Centre at Banstead UK. Fifty-four percent of clients were considered fit to continue driving where 9% could resume driving after car adaptation and training. Important factors for the outcome were vision (acuity and field), neuropsychological functions (divided attention), and track and/or on road test (reaction time, anticipation, speed, and positioning). Cognitive impairment was the main problem in those who failed the driving test and judged not fit for continued driving. Car adaptation, mainly comprising infrared transmitted secondary controls together with automatic transmission was recommended in 35% of the cases. CONCLUSIONS: The contribution of different specialist groups appears to be necessary for an effective evaluation, but the assessment procedure can be done more cost-effectively by dividing it into two separate parts and removing certain subtests. The in-car track test is an important part of the assessment procedure with a high face validity and could in many cases make it unnecessary to perform in-traffic tests with unsafe drivers. Car adaptation is often necessary for a client with pronounced hemi-paresis and a full road test can for those only be performed after training the use of car controls.


Subject(s)
Automobile Driving/psychology , Automobiles , Cognition Disorders/etiology , Interdisciplinary Communication , Stroke/complications , Adaptation, Physiological , Adolescent , Adult , Aged , Aged, 80 and over , Cognition , Female , Health Status , Health Status Indicators , Humans , Male , Middle Aged , Psychometrics , Risk Assessment , Vision Tests
13.
Eur J Neurol ; 15(2): 156-61, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18093153

ABSTRACT

Members of families with mutations in the tau gene are known to be heterogeneous in their clinical presentation, ranging from frontotemporal dementia to a clinical picture more resembling corticobasal degeneration or progressive supranuclear palsy. In this report, we describe a new phenotype for the tau S305S mutation, previously described as progressive supranuclear palsy. Clinically, the three affected family members showed alterations in personality and behaviour as well as cognitive decline and late levodopa-resistant parkinsonian symptoms, consistent with the diagnosis of frontotemporal dementia with parkinsonism linked to chromosome 17. One autopsied case displayed degeneration of the frontal and temporal lobes together with extensive tau pathology in both neurones and glial cells. Sarkosyl-soluble and -insoluble tau extracted from frontal cortex revealed a ratio shift with decreased levels of tau with three microtubule-binding repeats and increased levels of tau with four microtubule-binding repeats (4R tau). These findings provide further evidence for the clinical and pathological variation both within and between families with mutations in the tau gene. In addition, they support previous studies which demonstrate that the S305S mutation influences the splicing of tau exon 10 and results in an overproduction of 4R tau.


Subject(s)
Dementia/genetics , Mutation , Parkinsonian Disorders/genetics , tau Proteins/genetics , Adult , Amino Acid Substitution , Behavior , Brain/pathology , Cognition Disorders/etiology , Cysteine , Dementia/metabolism , Dementia/pathology , Dementia/psychology , Humans , Male , Parkinsonian Disorders/metabolism , Parkinsonian Disorders/psychology , Pedigree , Personality , Phenotype , Protein Isoforms/metabolism , Threonine , tau Proteins/metabolism
14.
Neurology ; 68(19): 1603-6, 2007 May 08.
Article in English | MEDLINE | ID: mdl-17485647

ABSTRACT

BACKGROUND: Patients with mild cognitive impairment (MCI) have increased risk to develop Alzheimer disease (AD). In AD increased brain amyloid burden has been demonstrated in vivo with PET using N-methyl-[(11)C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([(11)C]PIB) as a tracer. OBJECTIVE: To investigate whether patients with amnestic MCI would show increased [(11)C]PIB uptake, indicating early AD process. METHODS: We studied 13 patients with amnestic MCI and 14 control subjects with PET using [(11)C]PIB as tracer. Parametric images were computed by calculating the region-to-cerebellum ratio in each voxel over 60 to 90 minutes. Group differences in [(11)C]PIB uptake were analyzed with statistical parametric mapping (SPM) and automated region-of-interest (ROI) analysis. RESULTS: The SPM analysis showed that patients with MCI had significantly higher [(11)C]PIB uptake vs control subjects in the frontal, parietal, and lateral temporal cortices as well as in the posterior cingulate showing the most prominent differences. These results were supported by the automated ROI analysis in which MCI patients showed in comparison with healthy control subjects increased [(11)C]PIB uptake in the frontal cortex (39% increase from the control mean, p < 0.01), the posterior cingulate (39%, p < 0.01), the parietal (31%, p < 0.01) and lateral temporal (28%, p < 0.001) cortices, putamen (17%, p < 0.05), and caudate (25%, p < 0.05). Individually, in the frontal cortex and posterior cingulate, 8 of 13 patients with MCI had [(11)C]PIB uptake values above 2 SD from the control mean. MCI subjects having at least one APOE epsilon4 allele tended to have higher [(11)C]PIB uptake than MCI subjects without APOE epsilon4. CONCLUSIONS: At group level the elevated N-methyl-[(11)C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([(11)C]PIB) uptake in patients with mild cognitive impairment (MCI) resembled that seen in Alzheimer disease (AD). At the individual level, about half of the MCI patients had [(11)C]PIB uptake in the AD range, suggestive of early AD process.


Subject(s)
Alzheimer Disease/diagnostic imaging , Benzothiazoles , Brain/diagnostic imaging , Cognition Disorders/diagnostic imaging , Plaque, Amyloid/diagnostic imaging , Positron-Emission Tomography/methods , Aged , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Amnesia/diagnostic imaging , Amnesia/metabolism , Amnesia/physiopathology , Amyloid beta-Peptides/metabolism , Aniline Compounds , Brain/metabolism , Brain/physiopathology , Brain Mapping , Cognition Disorders/metabolism , Cognition Disorders/physiopathology , Female , Humans , Male , Plaque, Amyloid/metabolism , Predictive Value of Tests , Thiazoles
15.
Eur J Clin Nutr ; 61(12): 1352-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17299476

ABSTRACT

OBJECTIVE: Absorption of stearic acid from natural oils has been shown to be efficient, but it is claimed to be lower from short- and long-acyl-chain triacylyglycerol molecules (Salatrim). The aim was to measure the apparent absorption of stearic acid from Salatrim fat in an acute test meal. DESIGN: Double-blind crossover study. SUBJECTS: Ten healthy male volunteers, of whom eight completed the study. METHODS: The subjects were studied on two occasions after consumption of a single high-fat meal either without (control) or with 30 g of Salatrim. Fecal samples were collected for 96 h after the meal and the fat was extracted for analysis of the content and composition of free and esterified long-chain fatty acids. RESULTS: Baseline fecal fat was 5.6+/-2.6 g/day increasing to 10.4+/-4.9 g/day after addition of Salatrim (P=0.001). During the whole collection period, the baseline fecal free and esterified fatty acids were 2.6+/-2.3 and 0.8+/-0.7 g, respectively. After Salatrim meal the corresponding figures increased to 5.9+/-3.6 g (P=0.001) and 1.5 (+/-1.2) g (P=0.003), respectively. The total fecal stearic acid after control meal was 0.97+/-0.9 g. Consumption of Salatrim with 16.7+/-0.5 g of stearic acid increased the content to 3.12+/-1.6 g (P<0.001), with apparent absorption of 87%. CONCLUSIONS: The apparent absorption of stearic acid does not differ from its absorption from natural fats. The status of Salatrim as a low-energy fat substitute needs to be re-evaluated. SPONSORSHIP: University of Turku.


Subject(s)
Feces/chemistry , Intestinal Absorption/drug effects , Stearic Acids/pharmacokinetics , Triglycerides/chemistry , Adult , Cross-Over Studies , Diet, Fat-Restricted , Double-Blind Method , Fatty Acids/analysis , Fatty Acids, Nonesterified/analysis , Humans , Male , Triglycerides/pharmacokinetics
16.
Brain ; 130(Pt 2): 357-67, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17235124

ABSTRACT

Several hereditary small vessel diseases (SVDs) of the brain have been reported in recent years. In 1977, Sourander and Wålinder described hereditary multi-infarct dementia (MID) in a Swedish family. In the same year, Stevens and colleagues reported chronic familial vascular encephalopathy in an English family bearing a similar phenotype. These disorders have invariably been suggested to be cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) but their genetic identities remain unknown. We used molecular, radiological and neuropathological methods to characterize these disorders. Direct DNA sequencing unexpectedly confirmed that affected members of the English family carried the R141C mutation in the NOTCH3 gene diagnostic of CADASIL. However, we did not detect any pathogenic mutations in the entire 8091 bp reading frame of NOTCH3 or find clear evidence for NOTCH3 gene linkage in the Swedish DNA. This was consistent with the lack of hyperintense signals in the anterior temporal pole and external capsule in Swedish subjects upon magnetic resonance imaging. We further found no evidence for granular osmiophilic material in skin biopsy or post-mortem brain samples of affected members in the Swedish family. In addition, there was distinct lack of NOTCH3 N-terminal fragments in the cerebral microvasculature of the Swedish hereditary MID subjects compared to the intense accumulation in the English family afflicted with CADASIL. Several differences in arteriosclerotic changes in both the grey and white matter were also noted between the disorders. The sclerotic index values, density of collagen IV immunoreactivity in the microvasculature and number of perivascular macrophages were greater in the English CADASIL samples compared to those from the Swedish brains. Multiple approaches suggest that the Swedish family with hereditary MID suspected to be CADASIL has a different novel disorder with dissimilar pathological features and belongs to the growing number of genetically uncharacterized familial SVDs.


Subject(s)
CADASIL/genetics , Dementia, Multi-Infarct/genetics , Receptors, Notch/genetics , Adult , Brain/blood supply , Brain/ultrastructure , Chromosome Mapping/methods , DNA Mutational Analysis/methods , Dementia, Multi-Infarct/metabolism , Dementia, Multi-Infarct/pathology , Female , Humans , Intracranial Arteriosclerosis/genetics , Intracranial Arteriosclerosis/pathology , Magnetic Resonance Imaging , Male , Microcirculation/metabolism , Middle Aged , Mutation , Pedigree , Polymerase Chain Reaction/methods , Receptor, Notch3 , Receptors, Notch/metabolism , Skin/ultrastructure
17.
Neurology ; 67(9): 1575-80, 2006 Nov 14.
Article in English | MEDLINE | ID: mdl-16971697

ABSTRACT

BACKGROUND: PET studies with N-methyl-[(11)C]2-(4':-methylaminophenyl)-6-hydroxybenzothiazole ([(11)C]PIB) have revealed an increased tracer uptake in several brain regions in Alzheimer disease (AD). OBJECTIVE: To employ voxel-based analysis method to identify brain regions with significant increases in [(11)C]PIB uptake in AD vs healthy control subjects, indicative of increased amyloid accumulation in these regions. METHODS: We studied 17 patients with AD and 11 control subjects with PET using [(11)C]PIB as tracer. Parametric images were computed by calculating a region-to-cerebellum ratio over 60 to 90 minutes in each voxel. Group differences in [(11)C]PIB uptake were analyzed with statistical parametric mapping (SPM) and automated region-of-interest (ROI) analysis. RESULTS: SPM showed increased uptake (p < 0.001) in the frontal, parietal, and lateral temporal cortices as well as in the posterior cingulate and the striatum. No significant differences in uptake were found in the primary sensory and motor cortices, primary visual cortex, thalamus, and medial temporal lobe. These results were supported by automated ROI analysis, with most prominent increases in AD subjects in the frontal cortex ([(11)C]PIB uptake 163% of the control mean) and posterior cingulate (146%) followed by the parietal (146%) and temporal (145%) cortices and striatum (133%), as well as small increases in the occipital cortex (117%) and thalamus (115%). CONCLUSIONS: Voxel-based analysis revealed widespread distribution of increased [(11)C]PIB uptake in Alzheimer disease (AD). These findings are in accordance with the distribution and phases of amyloid pathology in AD, previously documented in postmortem studies.


Subject(s)
Alzheimer Disease/diagnostic imaging , Amyloid beta-Peptides/metabolism , Benzothiazoles/pharmacokinetics , Brain/diagnostic imaging , Carbon Radioisotopes , Positron-Emission Tomography/methods , Aged , Aged, 80 and over , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Aniline Compounds , Brain/metabolism , Brain/physiopathology , Brain Mapping/methods , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/metabolism , Cerebral Cortex/physiopathology , Corpus Striatum/diagnostic imaging , Corpus Striatum/metabolism , Corpus Striatum/physiopathology , Female , Humans , Image Processing, Computer-Assisted/methods , Ligands , Male , Middle Aged , Predictive Value of Tests , Thiazoles , Up-Regulation/physiology
19.
Dement Geriatr Cogn Disord ; 22(1): 99-107, 2006.
Article in English | MEDLINE | ID: mdl-16710090

ABSTRACT

BACKGROUND: Lifestyle and vascular factors have been linked to dementia and Alzheimer's disease (AD), but the role of dietary fats in the development of dementia is less clear. METHODS: Participants were derived from random, population-based samples initially studied in midlife (1972, 1977, 1982, or 1987). Fat intake from spreads and milk products was assessed using a structured questionnaire and an interview. After an average follow-up of 21 years, a total of 1,449 (73%) individuals aged 65-80 years participated in the re-examination in 1998. Altogether 117 persons had dementia. RESULTS: Moderate intake of polyunsaturated fats at midlife decreased the risk of dementia even after adjustment for demographic variables, other subtypes of fats, vascular risk factors and disorders, and apolipoprotein E (ApoE) genotype (OR 0.40, CI 0.17-0.94 for the 2nd quartile vs. 1st quartile), whereas saturated fat intake was associated with an increased risk (OR 2.45, CI 1.10-5.47 for the 2nd quartile). The associations were seen only among the ApoE epsilon4 carriers. CONCLUSIONS: Moderate intake of unsaturated fats at midlife is protective, whereas a moderate intake of saturated fats may increase the risk of dementia and AD, especially among ApoE epsilon4 carriers. Thus, dietary interventions may potentially modify the risk of dementia, particularly among genetically susceptible individuals.


Subject(s)
Alzheimer Disease/epidemiology , Dementia/epidemiology , Dietary Fats/adverse effects , Feeding Behavior , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Apolipoprotein E4 , Apolipoproteins E/genetics , Cholesterol/blood , Data Collection , Dementia/genetics , Dietary Fats, Unsaturated/adverse effects , Female , Finland/epidemiology , Follow-Up Studies , Heterozygote , Humans , Male , Middle Aged , Population , Prospective Studies , Risk , Socioeconomic Factors , Surveys and Questionnaires
20.
Acta Anaesthesiol Scand ; 49(7): 1015-22, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16045665

ABSTRACT

BACKGROUND: As part of a quality assurance program, we investigated the incidence of postpartum neurologic symptoms in multiparous parturients receiving spinal block for labour analgesia, now in routine use in our labour ward. METHODS: Two hundred and twenty-nine consecutive multiparous parturients presenting for vaginal delivery and requesting spinal analgesia were asked to participate in this prospective study. All parturients received our standard intrathecal analgesia (ITA): 2.5 mg bupivacaine (1 ml) + 25 microg fentanyl (0.5 ml) using a 27-gauge Quincke-type needle. The patients filled in a questionnaire on the first day after delivery and again upon discharge. Complaints typical of neurologic sequelae were noted and a neurologic examination was performed, if necessary. All patients with postdural puncture headache (PDPH) and transient neurologic symptoms (TNSs) were interviewed by telephone 2 weeks after discharge to determine the course of the symptoms. RESULTS: Two hundred and twelve parturients were included in the study. Eighteen (8.5%) parturients complained of PDPH, the severity of which was mild in eight (4%), moderate in seven (3%), and severe in three (1%) patients, respectively. Fifteen (7%) mothers were treated with analgesics or bedrest only. Three (1%) patients were given an epidural blood patch. The paramedian approach was associated with the development of PDPH (P = 0.04). Transient neurologic symptoms were experienced by nine (4.2%) mothers, lasting 1-3 days, mostly presenting as bilateral pain in the buttocks or thighs. One parturient suffered from paraesthesia of the left foot lasting for 3 days. Forty (19%) mothers complained of non-postural headache and 28 (13%) of new-onset back pain. Three mothers (1%) would not want to receive a further spinal block. CONCLUSION: Transient neurologic symptoms (TNSs) after spinal block occurred infrequently. The incidence of PDPH was higher than in the obstetric population in general and calls for re-evaluation of our spinal block methods. Despite the occurrence of neurologic sequelae, patient acceptability was high.


Subject(s)
Analgesia, Obstetrical/adverse effects , Anesthesia, Spinal/adverse effects , Headache/epidemiology , Spinal Cord/drug effects , Adult , Female , Humans , Incidence , Middle Aged , Pregnancy , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...